trial · primary record
Continuous Hetrombopag for 2 Cycles
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 126 |
| Primary completion | 2028-03-31 |
| Primary endpoint | Incidence of grade ≥2 thrombocytopenia (PLT < 75×10⁹/L) |
| Registry ID | NCT07647029 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:02.373Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07647029
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.